Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming

Hao Wu(University of Würzburg), Xiufeng Zhao(University of Würzburg), Sophia M. Hochrein(University of Würzburg), Miriam Eckstein(University of Würzburg), Gabriela Farias Gubert(University of Würzburg), Konrad Knöpper(University of Würzburg), Ana Maria Mansilla(University of Würzburg), Arman Öner(Ludwig-Maximilians-Universität München), Rémi Doucet-Ladevèze(University of Würzburg), Werner Schmitz(University of Würzburg), Bart Ghesquière(VIB-KU Leuven Center for Cancer Biology), Sebastian Theurich(German Cancer Research Center), Jan Dudek(University of Würzburg), Georg Gasteiger(University of Würzburg), Alma Zernecke(Universitätsklinikum Würzburg), Sebastian Kobold(German Cancer Research Center), Wolfgang Kastenmüller(University of Würzburg), Martin Vaeth(University of Würzburg)
Nature Communications
October 27, 2023
Cited by 261Open Access
Full Text

Abstract

T cell exhaustion is a hallmark of cancer and persistent infections, marked by inhibitory receptor upregulation, diminished cytokine secretion, and impaired cytolytic activity. Terminally exhausted T cells are steadily replenished by a precursor population (Tpex), but the metabolic principles governing Tpex maintenance and the regulatory circuits that control their exhaustion remain incompletely understood. Using a combination of gene-deficient mice, single-cell transcriptomics, and metabolomic analyses, we show that mitochondrial insufficiency is a cell-intrinsic trigger that initiates the functional exhaustion of T cells. At the molecular level, we find that mitochondrial dysfunction causes redox stress, which inhibits the proteasomal degradation of hypoxia-inducible factor 1α (HIF-1α) and promotes the transcriptional and metabolic reprogramming of Tpex cells into terminally exhausted T cells. Our findings also bear clinical significance, as metabolic engineering of chimeric antigen receptor (CAR) T cells is a promising strategy to enhance the stemness and functionality of Tpex cells for cancer immunotherapy.


Related Papers